AA
NPSP

Apriem Advisors’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Apriem Advisors’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-148
Closed -$5K – 547
2013
Q3 		$5K Buy
+148
New +$3.4K ﹤0.01% 415

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Apriem Advisors's NPSP Position: Q4 2013 in Review

Apriem Advisors sold out of NPS PHARMACEUTICALS INC (NPSP) in Q4 2013, closing a stake of 148 shares — an estimated $5K sold.

Apriem Advisors first reported a position in NPSP in Q3 2013 and held it in 1 quarter. The position peaked at $5K in Q3 2013. 191 funds tracked by Wall St. Rank hold NPSP as of Q4 2013.

  • Apriem Advisors reported no remaining NPS PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Apriem Advisors sold 148 NPS PHARMACEUTICALS INC shares in Q4 2013, an estimated $5K.
  • Apriem Advisors first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Apriem Advisors's NPS PHARMACEUTICALS INC position peaked at $5K in Q3 2013.
  • 191 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q4 2013.

Based on Apriem Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.